Also trades as: ABDXF (OTC) · $vol 0M
ABDX.L LSE
Abingdon Health Plc
1W: +0.7%
1M: -1.7%
3M: +3.1%
YTD: +76.2%
1Y: +92.2%
3Y: +0.7%
5Y: -83.0%
£10.57 ($0.14)
-0.43 (-3.95%)
Weekly Expected Move ±3.8%
£10
£10
£11
£11
£11
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$8M
+37.4% ▲
5Y CAGR: +10.0%
Gross Profit
$3M
-15.0% ▼
5Y CAGR: -5.2%
Operating Income
-$4M
-193.2% ▼
Net Income
-$3M
-168.7% ▼
EPS (Diluted)
$-0.01
-121.4% ▼
EBITDA
-$3M
-240.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $12M | $3M | $4M | $6M | $8M |
| YoY Growth | +121.9% | -75.6% | +42.7% | +51.7% | +37.4% |
| Cost of Revenue | $8M | $8M | $3M | $2M | $5M |
| Gross Profit | $3M | -$5M | $1M | $4M | $3M |
| Gross Margin | 29.2% | -184.4% | 34.7% | 60.0% | 37.1% |
| R&D Expenses | $503K | $182K | $0 | $0 | $0 |
| SG&A Expenses | $8M | $7M | $5M | $5M | $8M |
| Operating Expenses | $9M | $7M | $5M | $5M | $7M |
| Operating Income | -$6M | -$12M | -$4M | -$1M | -$4M |
| Operating Margin | -47.5% | -427.0% | -95.1% | -22.4% | -47.8% |
| Interest Expense | $234K | $69K | $75K | $57K | $75K |
| Income Before Tax | -$7M | -$22M | -$4M | -$1M | -$4M |
| Tax Expense | $19K | -$331K | -$105K | -$128K | -$390K |
| Net Income | -$7M | -$21M | -$3M | -$1M | -$3M |
| Net Margin | -60.0% | -750.0% | -85.8% | -20.7% | -40.5% |
| EPS (Diluted) | $-0.07 | $-0.07 | $-0.01 | $-0.00 | $-0.01 |
| EBITDA | -$6M | -$20M | -$3M | -$916K | -$3M |
| Shares Outstanding | 96M | 292M | 306M | 305M | 367M |